Antiplatelet and Anticoagulant management for Regional Anesthesia

Similar documents
ANAESTHESIA FOR LIVER SURGERY

NEURAXIAL BLOCKADE AND ANTICOAGULANTS

Timing of Surgery After Percutaneous Coronary Intervention

Funding: The ASRA Consensus Conference was funded by unrestricted educational grants from: Pharmacia & Upjohn Company and Aventis Pharmaceuticals

ANTI COAGULATION AND BLOCKS

Anesthesia for Total Hip and Knee Arthroplasty

Consensus Statement for Management of Anticoagulants and Antiplatelet drugs in Patients with Hip Fracture

Role and safety of epidural analgesia

Perioperative VTE Prophylaxis

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI

Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

Disclosures: This presenter has no financial relationships with commercial interests.

Top 5 (or so) Hematology Consults. Tom DeLoughery, MD FACP FAWM. Oregon Health and Sciences University DISCLOSURE

Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital

Regional anaesthesia and antithrombotic drugs

Dual Antiplatelet Therapy Made Practical

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Post-procedure dose ok after hours. 12 hours (q 24h dosing only) assuming surgical hemostasis; second dose 24 hours after first dose.

ASA Closed Claims Project: Regional Anesthesia Claims 1990 or later Lorri A. Lee MD Department of Anesthesiology University of Washington, Seattle, WA

Analgesia for ERAS programs. Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital

Anticoagulation for prevention of venous thromboembolism

Adjunctive Antithrombotic for PCI. SCAI Fellows Course December 9, 2013

Preoperative Management of Patients Receiving Antithrombotics

ANTITHROMBOTIC THERAPY 2010 Antitrombotik tedavi alan hastalarda operasyon hazırlığı

Venous Thromboembolism Prophylaxis: Checked!

2010, Metzler Helfried

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None

The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

Current evidence in acute pain management. Jeremy Cashman

ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT

Bleeding Management Strategies. Aiming for the best Outcomes August 27, Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM

There are many advantages of spinal or epidural analgesia/anesthesia

Outpatient Total Knee Arthroplasty: Anesthetic Implications

REGIONAL/LOCAL ANESTHESIA and OBESITY

Tailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI

Dental Management Considerations for Patients on Antithrombotic Therapy

Guideline Quick View: Venous Thromboembolism

Asif Serajian DO FACC FSCAI

Keywords: Peripheral nerve blocks for total hip arthroplasty; common anticoagulation medications; anticoagulation in regional anesthesia

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

ASA PLAVIX AND PREOPERATIVE OPTIMIZATION. John Hann, MD

ADVOCATE HEALTHCARE GUIDELINE FOR ANTITHROMBOTIC REVERSAL

Dr Ben Edwards Consultant Anaesthetist Sheffield Teaching Hospitals

SESSION 5 2:20 3:35 pm

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Adjunctive Antithrombotic for PCI. SCAI Fellows Course December 8, 2014

Nerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital

GUIDELINES FOR PERIPHERAL NERVE / PLEXUS BLOCK CATHETER MANAGEMENT DEPARTMENT OF ANAESTHESIOLOGY AND INTENSIVE CARE HOSPITAL KUALA LUMPUR

Venous Thromboembolism Prophylaxis

Dr Brigitta Brandner UCLH

Xarelto (rivaroxaban) Prescriber Guide

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct

DISCLOSURE. What I am Talking About. Rational Use of Antiplatelet Agents. Aspirin. Tom DeLoughery, MD MACP FAWM

Perioperative Pain Management

COMPLICATIONS AND INTERVENTIONS ASSOCIATED WITH EPIDURAL ANALGESIA FOR POSTOPERATIVE PAIN RELIEF IN A TERTIARY CARE HOSPITAL

ERAS: Enhanced Recovery After Surgery. Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland

This Epidural Catheter Is Not Working Well. What Should I Do? Miguel A. Cruz, M.D. Cleveland Clinic Foundation, Cleveland, OH

Milestone Guide. CBD Anesthesia

Complications and contraversies in the practice of neuraxial anaesthesia

Intravenous lidocaine infusions. Dr Ian McConachie FRCA FRCPC

Orthopedic Surgery for Adults with Cerebral Palsy- Medical Considerations. Disclosures. Objectives. Adults with Cerebral Palsy

Slide 1: Perioperative Management of Anticoagulation

Perioperative Management of anticoagulant medications

Multi-Modal Pain Management

Clinical Controversies in Perioperative Medicine

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.

Preoperative Cardiac Evaluation:

Objectives 9/7/2012. Optimizing Analgesia to Enhance the Recovery After Surgery CME FACULTY DISCLOSURE

Regional Anesthesia. Fatiş Altındaş Dept. of Anesthesiology

Xarelto rivaroxaban Prescriber Guide

Update in Perioperative Anticoagulation and Antiplatelet management

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Keeping Coronary Stents Patent in Patients Priya Kumar, M.D. University of North Carolina, Chapel Hill, NC

Antiplatelet and Anticoagulant Therapy Management Surrounding Regional Anesthesia

Thoracic epidural anesthesia and epidural hematoma.

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS

WARFARIN: PERI OPERATIVE MANAGEMENT

Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation

Acute Coronary Syndromes

Coagulation management in epidural steroid injection

Prostate Biopsy Alerts

Update Update on Anaesthesia for c-section Dr Kerry Litchfield Consultant Anaesthetist Princess Royal Maternity Glasgow, Scotland

Sign up to receive ATOTW weekly -

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17

Red de Revistas Científicas de América Latina y el Caribe, España y Portugal. Universidad Autónoma del Estado de México

Factor Xa Inhibition in the Management of Venous Thromboembolism: Important Safety Information. Important Safety Information (cont d)

Which Patients are Too High Risk for Ambulatory Surgery?

Update on Antithrombotic Therapy in Acute Coronary Syndrome

Complications of Regional Anesthesia and Acute Pain Management

Aspirin as Venous Thromboprophylaxis

Index. Note: Page numbers of article titles are in boldface type.

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients

Transcription:

Antiplatelet and Anticoagulant management for Regional Anesthesia Deborah Richman MBCHB, FFA(SA) Director of Pre-Operative Services Department of Anesthesia Stony Brook MedicineStony Brook, NY SPAQI Immediate Past-President deborah.richman@stonybrookmedicine.edu The 13 th Annual Perioperative Medicine Summit Fort Lauderdale, Florida

Disclosures No financial disclosures SPAQI Immediate Past President #Periop2018 The 13 th Annual Perioperative Medicine Summit Fort Lauderdale, Florida

Learning Objectives After attending this session the learner will be able to: List the types and advantages of regional blocks Describe the risks of blocks Provide medication management instructions to patients on antiplatelet agents and anticoagulants, who are planning on a regional anesthesia technique for their procedure

Analgesia Intraop: Opiates IV neuraxial NSAIDs Acetaminophen Local Regional blocks Post op: IV or PO opiates and block catheters

Complications of analgesics Opiates Allergies Toxicity Side effects Histamine release PONV Respiratory depression Confusion Constipation Weakness/dizziness falls Tolerance/Addiction/Abuse Regional / local Allergies Toxicity Local effects Hematoma Infection Nerve injury

Regional anesthesia Abdominal Thoracic nerve blocks femoral/sciatic/adductor canal/ Field block brachial plexus/ nerve blocks/ Bier s block Lower extremity epidural/ intercostal/paravertebral Upper extremity spinal/ epidural/tap block ankle block/penile block Ophthalmology retrobulbar/peribulbar/subtenon/topical Risk of hematoma #Periop2018 Non compressible spaces Closed space spinal column

Neuraxial anesthesia / analgesia #Periop2018

Regional anesthesia any time you stick a needle anywhere, you run the risk of introducing infection, causing bleeding or damaging a nerve.

Spinal/epidural complications 1. Drug allergy or toxicity 2. Anatomic: Difficulty placing them Failed block 3. Bleeding Skin Sub-q Epidural hematoma 4. Back pain 5. Infection epidural abscess 6. Nerve damage 7. Spinal tap or persistent CSF leak post dural puncture headache(pdph) 8. High spinal 9. Hypotension Reviewing contraindications and avoiding block may be appropriate

Rare True incidence not known US: 3.7 million epidurals 1998-2010 OB epidurals: 0.6 per 100,000 Non-OB: 18.5 per 100,000 (1: 5450) Vascular surgery Teaching hospital High comorbidity score Rosero EB Acta Anesth Scand. Jul 2016. Vol 60,:6 pp 810 820 Sweden 1.26 million spinals and 450K epidurals 1990-1999 Spinal hematoma(1:158 000) < Epidural (1: 18 000) Obstetrics < other patients Females TKR / hip fracture 11/33 assoc with coagulopathy/thromboprophylaxis Moen V. Anesthesiology. 2004;101(4):950. Frequency is increasing and may be as high as 1 in 3000 in some patient populations. Risk factors Increasing age, Anatomical abnormalities of spine Underlying coagulopathy Procedural difficulty Indwelling neuraxial catheter with anticoagulation therapy Prompt diagnosis and management needed to prevent permanent neurological sequelae. #Periop2018 Neuraxial hematoma after anesthesia

Avoiding epidural hematoma 1. Careful patient selection 2. Meticulous technique 3. Appropriate medication management

Case 1 57 yr. old male for TKR under spinal anesthesia and femoral nerve block for analgesia Advantages Less DVT Less blood loss Less transfusion Better bone cement interface Better ROM of knee at 1 week and 30 days MI 14 months ago with PCI and DES Meds include DAPT ASA 81mg and Clopidogrel 75mg Cardiol. cleared patient; to hold both drugs for 5 days

ARS question Case 1 For the planned procedure and anesthesia you should recommend that he: A. Stays on DAPT perioperatively B. He should stop the ASA for 7 days and continue the clopidogrel C. He should stop the clopidogrel for 5 days and continue the ASA D. He should stop the clopidogrel for 7 days and continue the ASA E. You agree with his cardiologist - he should stop both clopidogrel and ASA for 5 days

The magnitude of incremental bleeding risk in patients treated with antiplatelet therapy who undergo surgery is uncertain (157,158). If P2Y12 inhibitor therapy needs to be held in patients being treated with DAPT after stent implantation, continuation of aspirin therapy if possible is recommended #Periop2018 Levine, GN, et al. http://circ.ahajournals.org/content/early/2016/03/28/cir.0000000000000404

Patient selection Benefit of regional vs. risk of holding anticoagulant/ antiplatelet therapy #Periop2018

2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery Choice of Anesthetic Technique and Agent Fleisher LA, et al.2014 ACC/AHA Perioperative Guideline http://circ.ahajournals.org/content/early/2014/07/31/cir.0000000000000106

Neuraxial vs. General Anesthesia 1. Lower-limb revascularization 1 No difference in MI rate 2. Abdominal aortic surgery 2 No difference in MI or ischemia rate 1. Barbosa FT etal. Cochrane Database Syst Rev. 2013;7:CD007083. 2. Norris EJ etal. Anesthesiology. 2001;95:1054-67. Conclusion regional not cardio-protective No benefit

2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery Perioperative Pain Management: Recommendations Class IIa 1. Neuraxial anesthesia for postoperative pain relief can be effective in patients undergoing abdominal aortic surgery to decrease the incidence of perioperative MI (348). (Level of Evidence:B) Class IIb 1. Perioperative epidural analgesia may be considered to decrease the incidence of preoperative cardiac events in patients with a hip fracture (349). (Level of Evidence: B) RCT: 64 patients - MI/HF/ischemia/AF Fleisher LA, et al.2014 ACC/AHA Perioperative Guideline http://circ.ahajournals.org/content/early/2014/07/31/cir.0000000000000106 349. Matot I, etal Anesthesiology. 2003;98:156-63. #Periop2018

Which is better? GA or neuraxial? Very few places where one is definitively better Regional blocks Longer to place Longer to discharge Deep vein thrombosis (DVT) reduced Less relevant in age of universal prophylaxis Blood loss reduced in total joint replacements Use of tranexamic acid makes this less relevant?cancer recurrence Opioid avoidance Direct effect on tumor cells Reduction of stress response Sekandarzad, MW. A&A May 2017. Vol 124(5), p 1697 1708

Does regional anaesthesia really improve outcome? Specific endpoints assessed Inflammation Cancer Stress Less opioids Platelet function GI function Mixed results. it remains unclear whether regional anaesthesia reduces mortality. However, regional anaesthesia offers superior analgesia over opioidbased analgesia, and a significant reduction in postoperative pain is still a worthwhile outcome. S. C. Kettner, etal. BJA 2011, vol107, Issue suppl i90-i95

Non-cardiac complications and choice of anesthesia Evidence is mixed and conflicting: Neuraxial better? GI/ileus - ERAS DVT 1 month mortality Post op confusion? Clinical significance Cost? Continuous analgesia No difference? PONV PE LOS Pneumonia #Periop2018

Avoiding epidural hematoma 1. Careful patient selection 2. Meticulous technique 3. Appropriate medication management Placement of block/catheter Removal of catheter Restarting medication

Medication management Simplify when possible to improve patient compliance

Supplements and Herbal agents Effect is minimal unless combined with other agents Surgeon usually wants these held Vit E Fish Oils Ginger Ginkgo Horlocker, TT. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p 64-101 Garlic Hold for 7 days Ginkgo and Ginger shorter t1/2 #Periop2018

1000 procedures with neuraxial Majority: ASA and NSAIDs N=25 Heparin No major bleeds/ neuro sequelae Conclusion: ASA and NSAIDs safe in the arthritic population who depend on drugs for mobility #Periop2018

Neuroaxial anesthesia and bleeding risk ASRA guidelines 1 : Supplements Herbals Aspirin NSAIDS Clopidogrel 7 days Prasugrel 7-10 days Ticagrelor 5-7 days Ticlopidine 14 days Coumadin normal INR Practically: Hold 4-5 doses depending on INR Check INR morning of surgery 1. Horlocker, TT. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p 64-101 https://www.asra.com/advisoryguidelines/article/1/anticoagulation-3rd-edition

57 yr. old male for TKR under spinal anesthesia and femoral nerve block for analgesia For the planned procedure and anesthesia you should recommend that he: A. Stays on DAPT perioperatively B. He should stop the ASA for 7 days and continue the clopidogrel C. He should stop the clopidogrel for 5 days and continue the ASA D. He should stop the clopidogrel for 7 days and continue the ASA E. You agree with his cardiologist - he should stop both clopidogrel and ASA for 5 days

Neuroaxial anesthesia and bleeding risk ASRA guidelines 1 : Heparin normal PTT 6 hours after IV. May do block if < 10 000 SC daily dose Delay dose till > 1 hr. after block placed LMWH - block Prophylactic dose 10-12 hours after last dose Therapeutic dose 24 hours after Fondaparinux no evidence: block not recommended Glycoprotein IIb/IIIa Abciximab 48 hours Tirofiban/eptifibatide 4-8 hours NOACs: next slide 1. Horlocker, TT. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p 64-101 https://www.asra.com/advisoryguidelines/article/1/anticoagulation-3rd-edition

Horlocker, TT. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p 64-101 https://www.asra.com/advisory-guidelines/article/1/anticoagulation-3rd-edition

Memorizing this for your practice ld o H d l al s g ru 7 r fo s y a d Please NO!! There is help #Periop2018

ASRA app $ / User friendly

Summary Consider: Risk of hematoma vs. advantage of block Risk of stopping ac/antiplt agent vs. advantage of block Refer to ASRA guidelines Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition) https://www.asra.com/advisory-guidelines/article/1/anticoagulation-3rd-edition Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications: https://journals.lww.com/rapm/fulltext/2015/05000/interventional_spine_and_pain_procedur es_in.2.aspx Multidisciplinary consultation for best individualized management plan

Selected References Horlocker, TT. ASRA guidelines. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p 64-101 Rosero EB, Joshi GP. Nationwide incidence of serious complications of epidural analgesia in the United States. Acta Anaesthesiol Scand 2016; 60:810. S. C. Kettner, H. Willschke, P. Marhofer; Does regional anaesthesia really improve outcome?, BJA: British Journal of Anaesthesia, Volume 107, Issue suppl_1, 1 December 2011, Pages i90 i95,

Thank you Deborah Richman MBCHB, FFA(SA) Stony BrookMedicine Stony Brook, NY SPAQI Immediate Past President deborah.richman@stonybrookmedicine.edu #Periop2018

Symptoms of spinal hematoma Severe back pain (38%) sensory (14%) motor deficit (46%) Urinary retention (6%) Not all of these symptoms have to be present at the same time. Paraplegia develop 12-18 hours #Periop2018 Vandermeulen EP. A&A 1994;79:1165-77